InterVenn Biosciences
Rachel Rice is a Scientist at InterVenn Biosciences since November 2019, previously holding the position of Senior Research Associate. Prior experience includes serving as an Undergraduate Research Assistant at Lebrilla Lab from January 2018 to June 2019, where Rachel received training in biosafety level 2, gained experience in cell culturing and sample preparation techniques, and conducted data analysis using Orbitrap mass spectrometry. Rachel has also presented at the Larock Conference on optimizing Orbitrap mass spectrometry for glycoproteomic analysis. Educationally, Rachel obtained a Bachelor of Science in Pharmaceutical Sciences from the University of California, Davis, between 2017 and 2019.
InterVenn Biosciences
1 followers
InterVenn Biosciences utilizes a proprietary high-throughput glycoproteomic interrogation platform using artificial intelligence and mass spectrometry for next-gen precision medicine. The company is working to find new solutions in ovarian, pancreatic, liver, prostate, and kidney cancer, together with applications from the Vista suite of solutions for treatment and monitoring, immune profiling, patient stratification, and disease progression.